Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
2020 · New England Journal of Medicine · 15K citations
https://doi.org/10.1056/nejmoa2034577
S
Satrajit Roychoudhury
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
85
Papers
17.3K
Citations
19
h-index
26
i10-index
Satrajit Roychoudhury is an academic researcher. The author has contributed to research in topics: Statistical Methods in Clinical Trials & Health Systems, Economic Evaluations, Quality of Life & Advanced Causal Inference Techniques. The author has an h-index of 19, co-authored 73 publications.
ORCID: 0000-0003-4001-3036Papers by this author
worksAlternative Analysis Methods for Time to Event Endpoints Under Nonproportional Hazards: A Comparative Analysis
2020 · Figshare · 45 citations
https://doi.org/10.6084/m9.figshare.11310851.v2
Robust Design and Analysis of Clinical Trials With Non-proportional Hazards: A Straw Man Guidance from a Cross-pharma Working Group
2021 · Figshare · 18 citations
https://doi.org/10.6084/m9.figshare.13574905.v1
Handling missing values in patient-reported outcome data in the presence of intercurrent events
2025 · BMC Medical Research Methodology · 6 citations
https://doi.org/10.1186/s12874-025-02510-8
Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
2025 · Dermatology and Therapy · 1 citations
https://doi.org/10.1007/s13555-025-01543-7
Conditional and Unconditional treatment effects in randomized clinical trials: Estimands, Estimation, and Interpretation
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.24796171.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat